News & Articles
Selected Filters:
EKF increase production of key component for COVID-19 testing regime
EKF Diagnostics expands into new manufacturing facility in Cardiff for PrimeStore MTM production
UK-wide study focuses on threats of new SARS-CoV-2 variants
This effort will study virus variants in the UK and South Africa and what that means for the transmission of SARS-CoV-2
Access your 2021 Scientific Resource Bundles
Kickstart your new year with this compilation of top eBooks, techniques, webinars and videos across a range of scientific topics
Lateral flow devices detect most infectious COVID-19 cases and could allow a safer relaxation of lockdown
Researchers have used Test and Trace data to find out why some individuals pass COVID-19 on to their contacts more easily than others
Hologic introduces 3D breast ultrasound imaging on SuperSonic MACH Systems in Europe
Advancement can enable greater certainty for providers and better outcomes for patients
Promega announces combined COVID-19/ influenza clinical test expansion
Expanded list of instruments and reagents allows more options for labs running CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay
Reliable and rapid antimicrobial resistance identification for appropriate therapy: Your questions answered
In this on-demand webinar, discover how to rapidly diagnose antimicrobial resistance for appropriate therapy
Fluidigm receives CE-IVD mark for saliva-based Advanta Dx SARS-CoV-2 RT-PCR assay for COVID-19
The extraction-free saliva-based test detects nucleic acid from the SARS-CoV-2 virus
Thermo Fisher Scientific to acquire point-of-care molecular diagnostics provider Mesa Biotech
The acquisition aims to meet continuing demand for COVID-related testing as well as develop point-of care tests for future infectious diseases
Sartorius partners with RoosterBio to advance cell and gene therapy manufacturing
The collaboration aims to advance the scale-up of hMSC manufacturing for regenerative medicine
ViiV Healthcare announces FDA approval of the first complete long-acting regimen for HIV treatment
Cabenuva allows virologically suppressed adults with HIV to maintain viral suppression with 12 dosing days per year
Syntekabio, Hanmi Science collaborate to develop COVID-19 treatments using drug repurposing technologies
The strategic collaboration aims to accelerate clinical trials and drive critical developments for promising COVID-19 treatments
University of Bern establishes a multidisciplinary center for research into infectious diseases and immunity
The new research center is to receive some 30 million Swiss Francs financial support from the Vinetum Foundation over a period of 10 years
Antibiotic Research UK welcomes INEOS Oxford Institute to combat antimicrobial resistance as an important step forward
The new institute aims to meet the urgent need to do more research into the antimicrobial resistance
Owlstone Medical introduces breath biopsy panel for respiratory diseases
Panel supports research to distinguish between types of chronic inflammatory airway disease including asthma, COPD and IPF
Mission Bio launches single-cell multi-omics system for faster development of precision cancer therapies
The integrated solution offers deeper insight into therapy resistance and relapse, saving billions in drug development costs
Urinary NMR diagnostics for inborn errors of metabolism using rule-based interpretation (for research use only)
Watch this on-demand webinar to learn about the potential of computer-assisted interpretation and linking disease markers identified by NMR to the metagene database
Methadone distribution with Socorex Calibrex bottle-top dispensers
Precision dosing of the liquid therapy is very important as it must correspond to each patient’s addiction level
Pfizer-BioNTech COVID-19 vaccine elicits antibodies that neutralize coronavirus mutations
These findings are crucial as rapidly spreading variants of SARS-CoV-2 have been reported in various countries
Arthritis drugs may help reduce mortality and time in ICU for sickest COVID-19 patients
Initial findings showed that tocilizumab, a drug used to treat arthritis, was likely to improve outcomes among critically ill COVID-19 patients
Tomatoes offer affordable source of Parkinson’s disease drug
A research team has used genetic modification (GM) to create a new tomato variety that contains high levels of natural L-DOPA
AstraZeneca’s COVID-19 vaccine authorized for emergency supply in the UK
Working with the UK government, first vaccinations are to begin early in the new year